RLX Technology Inc. (RLX) Earnings Call Transcript & Summary

March 10, 2023

New York Stock Exchange US Consumer Staples Tobacco earnings 40 min

Earnings Call Speaker Segments

Sam Tsang

executive
#1

Thanks so much. Hi, everybody, and thanks for joining RLX Technology’s conference call about the fourth quarter and full year 2022 results. Earlier today, the company’s financial and operational results went out via PR Newswire services and are now available online. You may also read the earnings press release by going to the IR section of our site at ir.relxtech.com. Joining us on today’s call are our CEO, Ms. Kate Wang; our CFO, Chao Lu; and me, Sam Tsang, Head of Investor Relations. Before we move on, please be aware that today’s discussion will include forward-looking statements made under the Safe Harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such statements usually include words like may, will, expect, targets, estimates, intend, believe, potential, continue or other similar expressions. Forward-looking statements carry inherent risks and uncertainties. The accuracy of these statements may be affected by a number of business risks and uncertainties that could cause actual results to differ materially from those projected or anticipated, and many of these factors are beyond our control. The company, its affiliates, advisors and representatives do not undertake any obligation to update these forward-looking statements, except as required under the applicable law. Please be aware that RLX Technology’s earnings press release and this conference call include discussions of unaudited GAAP financial measures as well as unaudited non-GAAP financial measures. RLX press release contains a reconciliation of the unaudited non-GAAP measures to the unaudited GAAP measures. I’ll now hand the call over to Ms. Kate Wang. Please go ahead.

Kate Wang

executive
#2

I appreciate that, Sam, and I want to thank all of you for taking the time to be with us on today's earnings conference call. The year 2022 brought challenges unlike anything we had seen before. A mix of disruptions tied to COVID along with a significant slate of fresh industry rules and policy changes affected how we ran things throughout the entire e-vapor sector. We took a careful look at where the market stood in light of that unstable climate and moved swiftly to adopt the updated policies and standards. Because our strategy worked well and our execution was solid, we kept operations running smoothly and made meaningful progress over the course of the year. On today's call, my plan is to begin by going over how the regulatory picture evolved during the past year and to call attention to what we did to meet the new obligations, and after that I'll turn to what we expect in 2023 along with our ESG-related initiatives. Let's begin with those major new rules. During March and April, the administrative measures covering e-cigarettes together with the National Standards came out one after the other, opening a fresh regulatory chapter for the e-vapor business. Over the months that followed, a collection of detailed guidelines, rules and measures was introduced. To make sure the bulk of the adjustments could be made, the authorities gave those taking part in the industry a transition period that ran through September 30, 2022. While that transition period was underway, we took a proactive approach to reshaping our business and got ready to satisfy the new requirements once the regulation took full effect on October 1, 2022. Our attention went to creating compliant new products — we refer to these in Chinese as Guo Biao, or GB products — and we submitted applications for the necessary license and approvals; we also prepared to shift every one of our sales onto the national transition platform as mandated. At the same time, we worked hard to improve our supply chain and make our organization leaner, which increased the company's agility and flexibility so we could better handle the shifting regulatory landscape as well as COVID-related disruption. Beyond the changes we made internally, we offered prompt assistance to the owners of our stores and to our distributors so that the entire value chain could transition smoothly. These steps turned out to be effective and put us in a strong position as the new period began. What's more, in June and July 2022, two of our subsidiaries were granted a license for manufacturing enterprise by the State Tobacco Monopoly Administration. To be specific, one of them was approved to manufacture e-liquid, while the other was approved to own the RELX brand and to manufacture RELX branded e-vapor rechargeable devices, cartridge products and other relevant products. We also phased out our older products step by step and started introducing our approved new products in an orderly way across the country, all while successfully migrating our sales to the national transaction platform; at present we provide four distinct lines of compliant devices spanning a range of price points, so we can serve the needs of varied groups of adult smokers, from customers who are price-sensitive to those who prize a premium finish and personalized appearance. In addition, we are steadily bringing out new cartridges to assess how our customers experience smoking. It's a pleasure to see a growing number of adult smokers choosing our new GB product. When we moved into Q4, we ran into yet another obstacle: the e-cigarette excise tax, announced on October 25 and put into effect on November 1. Since that point, as a maker of e-vapor products, a 36% excise levy has applied to what we sell to distributors, and that has squeezed our margins. To counter this, we have taken further steps on our cost structure so that we can operate more efficiently and keep profitability at a sound level. Our CFO is going to explain that in more detail afterward — shortly afterward. Even though these rules and this process pose difficulties for us and for the wider sector over the short run, we think they likewise bring about order and a sound operating climate that will serve every participant in the industry well over the long run. Looking ahead to 2023, we plan to capture what the clearer regulatory frameworks and China’s reopening make possible by drawing on three of our core strengths. The first is product development. Our R&D capabilities, which lead the industry, together with continuing spending on scientific research, let us quickly create and bring to market compliant offerings that satisfy the changing needs and preferences of consumers. Three years ago, our non-GAAP R&D expense ratio stood below 2%; by 2022 it had risen to 5.7%. Lately, we provide the market’s most varied product lineup, serving the differing requirements of adult smokers. We are confident that our R&D edge will let us hold onto this leading position once the regulatory era arrives. Second, product quality and brand equity. For the majority of e-vapor users, the RELX brand means quality in e-vapor products; this matters especially for devices that turn e-liquid into an aerosol drawn into the lungs, and quality is important to adult smokers and it is per month to IRX. We will keep concentrating hard on this foundation of our brand. Last, we will depend on our business resilience and strong execution. This marks the first occasion on which we have faced shifts and difficulties in the industry. Back in 2019, a prohibition on selling e-vapor products online pushed us to alter our approach overnight. We swiftly pivoted offline to our branded stores price model and won the favor of adult smokers through our distinctive mix of convenience, value and excellent products. That is thanks to our team’s creative — our solid business fundamentals and an enormous amount of hard work. We are also steadily getting beyond the hurdles created by the new regulations. Before I wrap up, I want to give a few updates on our ESG initiatives. Besides our work to grow the business under the new regulatory framework, we stayed committed to meeting our social responsibilities in 2022. For instance, our Pods Reborn recycling program, launched in September 2021, has reached a number of significant milestones. By the close of 2022, more than 10,000 stores across 282 cities nationwide had taken part in the program, with over 2.8 million cartridges gathered; those recycled components are processed centrally into cement clinkers and intermediary products used in cement production, which we then use to build roads, bridges and toilet in rural revitalization project. This environmentally friendly strategy enables us to conserve valuable resources so we can deliver improved housing via rural communities. Back in December 2022, our Pods Reborn recycling initiative received recognition as an innovative enterprise for rural revitalization at the southern metropolis states 2022 ESG annual ceremony — a price award honoring China's most forward-thinking ESG programs. On top of that, we've woven United Nations sustainable development goals into our social responsibility strategies. In April 2022, we introduced our net zero emission plan Aim for Zero, targeting carbon neutrality across our direct operations by 2033 and along the value chain by 2050. Our plans include launching zero emission products and zero emission factories, building a green supply chain partner, removing needless single-use plastic packaging, and cutting waste so we can reach our goal. We also motivate staff to embrace low carbon offices practice, which helps drive fulfillment of the company's carbon neutrality commitments throughout its value chain. Commitment to corporate responsibility has stood among our core values from the very beginning. We'll keep hunting for fresh and innovative approaches to strengthen this dedication to our society. To sum up, 2022 proved a difficult year for RLX and the whole e-vapor industry. Even so, we trust that our work and headway across the year set the stage for an improved 2023. As China reopens and the industry adapts to the new normal, we'll stay devoted to delivering premium products with superior performance that meet adult smokers' needs. We're certain our core competitive advantages will enable us to grasp opportunities and unlock our growth potential as we keep leading the industry in this new era. Having said that, I'll hand the call over to our CFO, Lu Chao, who will elaborate further on some of our last quarter's initiatives and walk through our operational and financial results in more detail.

Chao Lu

executive
#3

Thanks, Kate, and greetings to everyone. I'll walk you through how we performed financially in Q4 and across all of 2022. We wrapped up a volatile 2022 with a fourth quarter that proved particularly tough. It wasn't just our initial quarter operating under the fresh regulatory system — it also overlapped with major shifts in COVID circumstances and rules in China. Within this complicated landscape, we kept putting cost management first, which was a core piece of our approach all through 2022, made our supply chain and product design more efficient, and tweaked our prices to lessen the blow from these outside forces; during Q4, net revenue came in at RMB340 million. As I noted, the pandemic hurt our results, as did erosion caused by illegal goods stemming from gaps in how the new regulation was enforced. On the COVID front, roughly 40% of regions — among them Hunan, Hubei, Guizhou, Shandong, Yunnan, Jilin, Henan, Jiangxi, and others — halted orders for close to 1 month in Q4 owing to disruptions tied to the pandemic. At the same time, in-person foot traffic dropped sharply because of lockdowns and the enormous nationwide surge of infections, dealing a heavy blow to our sales. On a positive note, we observed in-person traffic starting to rebound steadily once the worst of the infection wave had subsided. The second issue involved illegal flavored goods. Under the national standards, as of October 1, only tobacco flavored items are permitted for sale in licensed retail outlets. We adhere strictly to the rules and have kept our top spot in the organized market; even so, illegal non-tobacco flavored items have hurt our sales, since some consumers are slow to embrace GB products while non-tobacco flavored alternatives stay on shelves. More positively, authorities nationwide have stepped up their crackdown on these unlawful goods. We're glad to report growing acceptance among consumers who have made the switch to GB products; across the entire year, our net revenue dropped 37% year-over-year, landing at RMB5.3 billion. That decline stemmed largely from pausing new product rollouts and store growth through the transition period, plus phasing out older items in the latter half of 2022. Turning to gross profit. We posted gross profit of about RMB148 million in Q4 of 2022, versus RMB766 million during the same stretch a year earlier. Our gross margin climbed 3.4 percentage points year-over-year, reaching 43.6% in Q4, driven by better supply chain efficiency and lower inventory provisions; nevertheless, gross margin slid 6.4 percentage points from the prior quarter, chiefly because of the 36% excise tax on e-vapor products that took effect in November. As I said, we've adjusted our pricing, product design, and supply chain in response and seen solid results; we'll keep looking for additional ways to ease the pressure further. For the whole year, gross profit totaled RMB2.3 billion, down from RMB3.7 billion the year before. Our gross profit margin held steady at 43%, largely driven by higher inventory provisions canceling out the gains we achieved in supply chain efficiency. Now to cost control, the area we have made our strategic priority all year. What we accomplished in 2022 paid off impressively, with potential yearly savings exceeding RMB141 million moving forward; during the fourth quarter, operating expenses came to RMB620.4 million, versus RMB231.5 million for the comparable period in 2021. That rise in operating expenses stemmed chiefly from shifts in share-based compensation expenses tied to fluctuations in our price. When share-based compensation is included, non-GAAP operating expenses for the fourth quarter reached RMB146 million, down 23% from a year earlier; across the whole of 2022, operating expenses totaled RMB1.2 billion, a 10% drop from RMB1.4 billion the year before. To break that down, selling expenses fell 33% to RMB348 million in 2022, down from RMB521 million the previous year, largely because of: first, lower share-based compensation expenses; and second, reduced branded material expenses. General and administrative expenses declined 14% to RMB577 million in 2022, from RMB673 million a year earlier, mostly as a result of lower share-based compensation expenses. R&D expenses rose 76% to RMB317 million in 2022, up from RMB180 million the prior year, chiefly because of higher salaries and welfare benefits, partly offset by reduced share-based compensation expenses. If share-based compensation is excluded, non-GAAP operating expenses for 2022 stood at RMB1.1 billion, a 6.5% decline year-over-year; through 2023 we will keep our focus squarely on cost control. Now on to profitability. Because of our disciplined cost management and solid execution, we sustained a healthy profitability level across 2022. Non-GAAP net income came in at RMB250 million for the fourth quarter of 2022, compared with RMB537 million during the same quarter of 2021. Non-GAAP basic and diluted net income per ADS stood at RMB0.188 and RMB0.186, respectively, for the fourth quarter of 2022. That compares with non-GAAP basic and diluted net income per ADS of RMB0.398 and RMB0.394, respectively, during the equivalent period of 2021. For the whole of 2022, non-GAAP net income reached RMB1.6 billion, while non-GAAP margin rose modestly by 3.1 percentage points to 29.5% in 2022. Non-GAAP basic and diluted net income per ADS came to RMB1.218 and RMB1.210, respectively, in 2022, versus non-GAAP basic and diluted net income per ADS of RMB0.604 and RMB1.591, respectively, a year earlier. Turning now to our balance sheet. At December 31, 2022, cash and cash equivalents, restricted cash, short-term bank deposits, short-term investments, long-term bank deposits and long-term investment securities totaled RMB15.73 billion, up from RMB14.86 billion at December 31, 2021. As we enter 2023, we will keep optimizing operational efficiency and cost control measures, sharpening our agility and our capacity to compete within the new regulatory environment. Our robust cash position will likewise enable us to pursue quality investments in R&D and product development. We think the strength of this company and its solid basics < > Yes, hello. I'm sorry about that dropped connection. As we move into 2023, we're going to keep sharpening how efficiently we run things and how tightly we manage costs, which makes us more nimble and better able to compete under the new regulatory landscape. The robust cash we hold will likewise give us the power to put quality money into R&D and product development. We think the strength of this company and its solid basics will let us get past the obstacles in the near term and prosper in this new era. As ever, we stay committed to building long-term sustainable value for our stakeholders; that wraps up our prepared remarks today. For more detail on our fourth quarter and full year 2022 financial results, please look at our earnings press release. We'll now take questions on the call. Operator, please go ahead.

Lydia Ling

analyst
#4

Hello, management. I appreciate the presentation. Lydia here from Citi Research. I've got a couple of questions. My first one: might you discuss the pattern you've seen lately, in both January and February, plus what customers are saying about the newly launched items and the updated pricing? Also, with the reopening happening and the government's push against things like illicit goods, at what level do you anticipate demand bouncing back this year? That's question one. Question two concerns margins. Because of the upward price adjustments throughout the value chain, plus tax — the consumption tax effect — what's your expectation for margin movement both this year and over the longer horizon? Thank you.

Chao Lu

executive
#5

Certainly. Lydia, many thanks for those questions. The first covers how demand will develop along with customer feedback. The second focuses primarily on the consumption tax and where margins are headed. On the first — demand outlook and customer behavior — we've lately observed month-over-month sequential gains. A handful of factors, we think, explain this. Factor one involves conversion. When people use up their pre-GB items, they'll naturally buy GB items made by us, since e-vapor has remained their primary nicotine source. Factor two is additional SKUs coming out, as we've been steadily bringing more SKUs featuring assorted tobacco flavors into the market. That way, customers can more readily locate the tobacco-flavored cartridge variant they favor. As for our outlook across the full year and how much recovery, frankly, it remains quite early and tough to give a precise numerical projection, for the reasons covered earlier in the remarks. Illicit goods being available has, to some degree, slowed the shift of our customers away from pre-GB items toward GB items meeting national standards. Lately, though, we are noticing progress, since the STMA has begun and rolled out a campaign against non-GB illicit goods at a broader scale, and we back such campaigns equally; so we observe, and anticipate observing, additional customers moving to tobacco-flavored GB items conforming to the newer requirements, once most non-compliant goods have been cleared from the marketplace. Turning to customer behavior, as noted during the prior earnings call, the Net Promoter Score — that is, the NPS — has been rising once customers use the items more often, and releasing additional SKUs in assorted tobacco flavors, with a variety of offerings available, could lift our items' NPS even more. Now, on the pricing side, we've implemented our initial adjustment to both the ex-factory selling price and the suggested retail price. That came after consumption tests were introduced last November. Since our products are essentials for them, most users have adjusted to this change. That said, we do notice a small group of users for whom the pricing might feel somewhat high. So, taking into account our continuous supply chain efficiency gains along with those user needs, we're going to revise pricing on certain SKUs beginning in April. Beyond that, we've made available a range of product offerings at different price points, such as entry level items like Xin Yu < >, so our products become more accessible by launching them across additional provinces. To illustrate, Xin Yu was offered in 23 provinces this January, compared with 16 provinces back in November of last year. As a result, we are indeed seeing demand recover. On your second question, which concerns consumption tax effects as well as the margin trend: our GPM did drop 6.4% quarter-over-quarter in the last quarter. That was primarily because of the consumption tax release, which likely took effect on November 1st. So investors and analysts should be able to get a fuller picture of how our consumption tax plays out during the first quarter of 2023. Naturally, we've already taken certain measures to soften the impact. First, our ex-factory selling price has been adjusted. Second, we've kept working on supply chain efficiency and product design in order to bring down our variable unit costs. These two efforts have assisted us in mitigating the effect brought about by the consumption tax release. Even though we've changed the price and reduced unit costs to partially safeguard gross margins, we want to remind analysts and investors that fixed costs have also been incurred on our side, such as depreciation within cost of revenue line items. Therefore, this affects what's distributable to OpEx cost, based on how much our sales volume recovers. In short, over the short and medium-term, we expect our gross margin to improve gradually, largely driven by sales volume recovery; over the long run, we'll keep enhancing supply chain efficiency and product mix to further bolster our margin profile. Thank you very much.

Charlie Chen

analyst
#6

Thanks, operator. I also have a couple of questions. The first is actually a follow-up on the matter of the price adjustment. You said that your gross margin ought to be improving. So I have a couple of questions about that. First, since you've already implemented all of those operating efficiencies, how do you expect your operating margin to trend from here? And second, what's the reasoning for these price adjustments, and do you have any additional plans for further price adjustments down the road? That covers the price adjustments. My next question concerns the share repurchase — the share buyback. How much have you completed, and what's your plan for the buyback over the next few months, or a year or so? Thank you.

Chao Lu

executive
#7

Thanks, Charlie. The first topic is the price adjustments, and the second topic is the share repurchase. From the standpoint of the absolute amount of our merchandise gross profit prior to deducting fixed costs like D&A and rental costs, the absolute gross profit amount per cartridge will fall by mid-single digits as a result of the price adjustments in April, assuming the unit cost remains unchanged. At the same time, our ex-factory selling price per cartridge will drop by an even greater degree after the price adjustments. So, if you work it out mathematically, our GPM will improve slightly. Since our new ex-factory selling prices take effect on April 17, 2023, we don't anticipate making price adjustments in the near term. As for operating margins, it hinges on our top line recovery. Right now, we're unable to give quantitative guidance on margins for this year, but we've already taken steps to boost our efficiency to limit the impact of reduced sales. Using 2022 as an example, our operating cost savings efforts could save us over RMB140 million on an annual basis. And the second topic is share rep. As we announced our $500 million share rep in December 2021 for a term of 2 years, we'll disclose the exact amount in our 20-F filings next month. The share rep program is largely on track with our internal plan. Our Board and management continually monitor capital market conditions, and we'll make the corresponding repurchases from time-to-time. Thank you for your questions.

Peihang Lyu

analyst
#8

Hello management team, I'm Lyu Peihang from CICC, and I appreciate the time and the presentation you've given us. Two things I'd like to ask about. First, how have cartridge sales volumes been lately for GB standard items, setting aside any distortion caused by unlawful products? Also, might you provide some outlook regarding the recovery that lies ahead? Second, we've observed that both your ex-factory and retail prices were reduced not long ago. I'm curious about what prompted that move, and how do you expect future project sales volume along with GPM change to look following the price cut? Thanks.

Chao Lu

executive
#9

Thanks for the question, Peihang. The first part concerns sales and how unlawful products have affected them. The second part relates to the price adjustments and their effect on our GB. Estimating the effect of those unlawful sales strikes me as hard, since such goods move through the black market. In particular, they aren't compliant, and those players remit no tax whatsoever. As a result, their transactions don't even occur on the national transaction platform. That's why estimating their volume, and likewise the effect on us — plus the effect on what we sell — strikes me as hard. As for how sales will look across the year, should these unlawful goods be curtailed in the market, what we're able to share at this point is this: the stores that carry only GB items, our direct own stores being one example, have shown, over recent months, a steady rise in sales per store. That said, these stores certainly do feel the effects of nearby outlets offering unlawful goods. So we believe the rebound would come even sooner than what we're observing, once those unlawful goods have been curtailed from the market. On the second part, regarding the price adjustments, the impact lands in April 2023. What drove the price adjustment chiefly is that we've observed further gains in our supply chain efficiency, which leaves us some room to adjust prices. Accordingly, we chose to revise our ex-factory selling price so as to better assist our retailers in getting through the tough period together with us. Once our ex-factory selling price adjustments are made, gross profit per cartridge will rise, producing greater profits in the end. In addition, we have 4 product lines spanning a range of price points. These price adjustments are meant to make the gross profit margins across each series more sensible as seen from the retailer's perspective. That should give retailers stronger incentive to push our various series of GB products. Finally, we want our products to become more within reach for users who are price-sensitive. Following the adjustments, we hope to see those users who put off their conversions because of pricing gain distinct incentives to adopt our GB products. Thanks for your question.

Chao Lu

executive
#10

We appreciate you being here with us once more. Should anything else come to mind, you're welcome to reach out to the Investor Relations team at RLX Technology using the details listed on our website, or to TPG Investor Relations.

Operator

operator
#11

Appreciate it. That brings today's conference call to a close. You're free to hang up your lines now. Thanks so much.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete RLX Technology Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to RLX Technology Inc. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in RLX Technology Inc. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.